Agency Information Collection Activities; Proposed Collection; Comment Request, 14805-14806 [2013-05302]
Download as PDF
<![CDATA[
14805
Federal Register / Vol. 78, No. 45 / Thursday, March 7, 2013 / Notices
Deadline: Comments on this
Information Collection Request must be
received within 60 days of this notice.
Dated: February 28, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–05303 Filed 3–6–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Information Collection Request Title:
The Stem Cell Therapeutic Outcomes
Database (OMB No. 0915–0310)—
[Revision]
Health Resources and Services
Administration
Agency Information Collection
Activities; Proposed Collection;
Comment Request
ACTION:
Reports Clearance Officer at (301) 443–
1984.
HRSA specifically requests comments
on: (1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Notice.
SUMMARY: In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects (section 3506(c)(2)(A) of Title
44, United States Code, as amended by
the Paperwork Reduction Act of 1995,
Pub. L. 104–13), the Health Resources
and Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, email
paperwork@hrsa.gov or call the HRSA
Abstract: The Stem Cell Therapeutic
and Research Act of 2005, Public Law
(Pub. L.) 109–129, as amended by the
Stem Cell Therapeutic and Research
Reauthorization Act of 2010, Public Law
111–264 (the Act), provides for the
collection and maintenance of human
blood stem cells for the treatment of
patients and research. HRSA’s
Healthcare Systems Bureau has
established the Stem Cell Therapeutic
Outcomes Database. Operation of this
database necessitates certain record
keeping and reporting requirements in
order to perform the functions related to
hematopoietic stem cell transplantation
under contract to the U.S. Department of
Health and Human Services (HHS). The
Act requires the Secretary to contract for
the establishment and maintenance of
information related to patients who
have received stem cell therapeutic
products and to do so using a
standardized, electronic format. Data is
collected from transplant centers by the
Center for International Blood and
Marrow Transplant Research and is
used for ongoing analysis of transplant
outcomes. HRSA uses the information
in order to carry out its statutory
responsibilities. Information is needed
to monitor the clinical status of
transplantation and to provide the
Secretary of HHS with an annual report
of transplant center-specific survival
data. The increase in burden is due to
an increase in the annual number of
transplants and increasing survivorship
after transplantation.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
The annual estimate of burden is as
follows:
2013—ESTIMATED
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Baseline Pre-TED (Transplant Essential Data) ...................
Product Form (includes Infusion, HLA, and Infectious Disease Marker inserts) ........................................................
100-Day Post-TED ...............................................................
6-Month Post-TED ...............................................................
12-Month Post-TED .............................................................
Annual Post-TED .................................................................
200
38
7,600
0.9
6,840
200
200
200
200
200
29
38
31
27
104
5,800
7,600
6,200
5,400
20,800
1.5
0.85
1
1
1
8,700
6,460
6,200
5,400
20,800
Total ..............................................................................
200
........................
53,400
........................
54,400
Submit your comments to
paperwork@hrsa.gov or mail the HRSA
emcdonald on DSK67QTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
18:42 Mar 06, 2013
Jkt 229001
Reports Clearance Officer, Room 10–29,
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857.
E:\FR\FM\07MRN1.SGM
07MRN1
14806
Federal Register / Vol. 78, No. 45 / Thursday, March 7, 2013 / Notices
Deadline: Comments on this
Information Collection Request must be
received within 60 days of this notice.
Dated: February 28, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–05302 Filed 3–6–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Statement of Organization, Functions
and Delegations of Authority;
Correction
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice; correction.
AGENCY:
SUMMARY: HRSA published a document
in the Federal Register of January 7,
2013 (FR Doc. 2013–00032), regarding
organizational changes that update the
functional statements for the Office of
Management. The administrative code
for the Division of Information
Technology (IT) Security and Records
Management was incorrectly written as
RBR at four occasions, on pages 956 and
957.
In the Federal Register of January 7,
2013, in FR Doc. 2013–00032, on pages
956 and 957, at four occasions, correct
the administrative code for the Division
of Information Technology (IT) Security
and Records Management to read RB5R.
Dated: February 28, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–05304 Filed 3–6–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
emcdonald on DSK67QTVN1PROD with NOTICES
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel: Clinically Relevant Variation Resource
RFA.
Date: March 14, 2013.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 4th Floor Conference Room, 5635
Fishers Lane, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280,
mckenneyk@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: March 1, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–05240 Filed 3–6–13; 8:45 am]
BILLING CODE 4140–01–P
Correction
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Mar<15>2010
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
18:42 Mar 06, 2013
Jkt 229001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel: Translational
Research.
Date: April 22, 2013.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 1, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–05239 Filed 3–6–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–4102–
DR; Docket ID FEMA–2013–0001]
Louisiana; Major Disaster and Related
Determinations
Federal Emergency
Management Agency, DHS.
AGENCY:
ACTION:
Notice.
SUMMARY: This is a notice of the
Presidential declaration of a major
disaster for the State of Louisiana
(FEMA–4102–DR), dated February 22,
2013, and related determinations.
DATES:
Effective Date: February 22,
2013.
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street SW.,
Washington, DC 20472, (202) 646–2833.
Notice is
hereby given that, in a letter dated
February 22, 2013, the President issued
a major disaster declaration under the
authority of the Robert T. Stafford
Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121 et seq.
(the ‘‘Stafford Act’’), as follows:
SUPPLEMENTARY INFORMATION:
I have determined that the damage in
certain areas of the State of Louisiana
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 78, Number 45 (Thursday, March 7, 2013)]
[Notices]
[Pages 14805-14806]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05302]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities; Proposed Collection;
Comment Request
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 104-13), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being developed for submission to the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995. To request more
information on the proposed project or to obtain a copy of the data
collection plans and draft instruments, email paperwork@hrsa.gov or
call the HRSA Reports Clearance Officer at (301) 443-1984.
HRSA specifically requests comments on: (1) The necessity and
utility of the proposed information collection for the proper
performance of the agency's functions, (2) the accuracy of the
estimated burden, (3) ways to enhance the quality, utility, and clarity
of the information to be collected, and (4) the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
Information Collection Request Title: The Stem Cell Therapeutic
Outcomes Database (OMB No. 0915-0310)--[Revision]
Abstract: The Stem Cell Therapeutic and Research Act of 2005,
Public Law (Pub. L.) 109-129, as amended by the Stem Cell Therapeutic
and Research Reauthorization Act of 2010, Public Law 111-264 (the Act),
provides for the collection and maintenance of human blood stem cells
for the treatment of patients and research. HRSA's Healthcare Systems
Bureau has established the Stem Cell Therapeutic Outcomes Database.
Operation of this database necessitates certain record keeping and
reporting requirements in order to perform the functions related to
hematopoietic stem cell transplantation under contract to the U.S.
Department of Health and Human Services (HHS). The Act requires the
Secretary to contract for the establishment and maintenance of
information related to patients who have received stem cell therapeutic
products and to do so using a standardized, electronic format. Data is
collected from transplant centers by the Center for International Blood
and Marrow Transplant Research and is used for ongoing analysis of
transplant outcomes. HRSA uses the information in order to carry out
its statutory responsibilities. Information is needed to monitor the
clinical status of transplantation and to provide the Secretary of HHS
with an annual report of transplant center-specific survival data. The
increase in burden is due to an increase in the annual number of
transplants and increasing survivorship after transplantation.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions, to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information, to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information, and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this Information Collection Request are summarized in the table below.
The annual estimate of burden is as follows:
2013--Estimated
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form name Number of responses per Total per response Total burden
respondents respondent responses (in hours) hours
----------------------------------------------------------------------------------------------------------------
Baseline Pre-TED (Transplant 200 38 7,600 0.9 6,840
Essential Data)................
Product Form (includes Infusion, 200 29 5,800 1.5 8,700
HLA, and Infectious Disease
Marker inserts)................
100-Day Post-TED................ 200 38 7,600 0.85 6,460
6-Month Post-TED................ 200 31 6,200 1 6,200
12-Month Post-TED............... 200 27 5,400 1 5,400
Annual Post-TED................. 200 104 20,800 1 20,800
-------------------------------------------------------------------------------
Total....................... 200 .............. 53,400 .............. 54,400
----------------------------------------------------------------------------------------------------------------
ADDRESSES: Submit your comments to paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10-29, Parklawn Building, 5600 Fishers
Lane, Rockville, MD 20857.
[[Page 14806]]
Deadline: Comments on this Information Collection Request must be
received within 60 days of this notice.
Dated: February 28, 2013.
Bahar Niakan,
Director, Division of Policy and Information Coordination.
[FR Doc. 2013-05302 Filed 3-6-13; 8:45 am]
BILLING CODE 4165-15-P
